Evidence map›Paper›PMID 41081166›Full record

ArticleQuantitative imaging in medicine and surgery2025

TransDualSegNet: transformer dual segment network for retinal vasculature segmentation in OCT.

Ligang Jiang, Jing Hu, Zhuoran Wang, Guohui Yuan, Chongjun Huang, Zhiming Xiong, Meizhen Zhang, Weihua Yang, Yuhua Tong

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ligang Jiang *Department of Ophthalmology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Jing Hu *Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Zhuoran WangYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Guohui YuanYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Chongjun HuangYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Zhiming XiongYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Meizhen ZhangQuzhou Kecheng People's Hospital, Quzhou, China.ORCID https://orcid.org/0009-0000-5691-3245
Weihua YangShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.ORCID https://orcid.org/0000-0002-7629-0193
Yuhua TongDepartment of Ophthalmology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The early diagnosis and treatment of eye diseases is crucial for preserving vision, and optical coherence tomography (OCT) has become a common non-invasive technique for eye examinations. In particular, retinal vessel segmentation in OCT images is a critical task that provides detailed information such as vessel diameter and wall thickness, serving as important diagnostic aids for ophthalmologists. This study aimed to develop an efficient and accurate retinal vessel segmentation method in OCT images to improve the diagnosis and treatment of eye diseases. Methods: Transformer Dual Segment Network (TransDualSegNet) involves several key steps: firstly, the OCT images are preprocessed through denoising and brightness adjustment to enhance the performance of subsequent segmentation algorithms. Secondly, we introduce an encoder-decoder model with the Pyramid Vision Transformer as the encoding layer, which automatically learns the feature representation of retinal vessels to improve segmentation accuracy and robustness. The decoder utilizes a dual-branch convolutional network that incorporates and emphasizes the edge information of retinal vessel OCT images as complementary information for vessel segmentation. Finally, a feature fusion module (FFM) is applied to fuse the global features and edge features, which are fed into the edge extraction module to generate the final edge probability map and obtain the segmentation results. Results: Experimental results on the OCT vessel segmentation dataset showed that the proposed model outperformed U-Net, Attention U-Net, and Trans U-Net, with accuracy (ACC) 91.13%±0.11%, sensitivity (SE) 90.02%±0.38%, Jaccard similarity (JS) 93.92%±0.13%, and Dice coefficient (DICE) 90.26%±0.25% all higher than comparisons. The model has 9.82 M parameters, falling between the comparison models, and a forward inference time of 20.3 ms, faster than Attention U-Net and Trans U-Net, balancing high accuracy and efficiency. Ablation experiments showed that it outperformed all sub-models in metrics such as ACC, SE, specificity (SP), Intersection over Union (IOU), and area under the curve (AUC), with IOU reaching 93.92%±0.13% and AUC 93.04%±0.34%, verifying the synergistic effectiveness of each component. Conclusions: TransDualSegNet, with its innovative architecture and outstanding segmentation performance, offers a novel solution for retinal vessel segmentation. Although there is room for optimization, its technical advantages and clinical potential provide valuable insights for advancing medical image processing and ophthalmic diagnostic technologies. Precise retinal vessel segmentation aids in diagnosing diabetic retinopathy and hypertensive retinopathy, facilitating automatic measurement of parameters such as vessel diameter and wall thickness to offer more accurate treatment recommendations for patients.

Indexed as

artificial intelligencedeep learningOphthalmic medical image processingoptical coherence tomography (OCT)ultra-fine semantic segmentation

Identifiers

PMID41081166
PMCPMC12514643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.